CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • What’s in Your Glass? Weighing the Health Risks of Alcohol Consumption

    “Just one for the road.” We’ve all heard or said this at a party. Alcohol is a…
    June 28, 2024| Ajit Muley, PhD
  • CRI’s 5th Annual Wear White Luncheon Raises Over $40,000

    On Thursday, June 20, 2024, the Cancer Research Institute (CRI) celebrated its fifth annual Wear White Luncheon,…
    June 25, 2024| CRI Staff
  • Keytruda Receives 40th FDA Approval

    This week marked a significant milestone in the fight against cancer. On June 17, the FDA approved…
    June 21, 2024| Ajit Muley, PhD
  • Immunotherapy’s Visible Promise Against Head and Neck Cancer

    The drummer for the rock band Poison, Rikki Rockett, has made a name and a living for…
    April 4, 2024| Max Mallet
  • Can a simple blood test tell you how your cancer therapy works? 

    According to a recent study published in Nature Medicine, blood from patients can be used to screen…
    March 29, 2024| Ajit Muley, PhD
  • Exploring the Impact of Substance Use on Cancer Immunotherapy

    Alcohol and illicit drugs are common carcinogens that immunotherapy research is actively seeking to more thoroughly detail…
    March 22, 2024| Max Mallet
  • Dive into the Future of Immuno-Oncology with Our Experts in February’s IO Insights 

    The Cancer Research Institute (CRI) is thrilled to announce that the February issue of IO Insights is…
    March 13, 2024| Ajit Muley, PhD
  • Peggy Zuckerman is a Resilient Kidney Cancer Survivor and Here’s Why She is a Passionate Advocate for Awareness

    In 2004, North Dakota resident and educator Peggy Zuckerman was told by her doctor that she had…
    March 12, 2024| Max Mallet
  • Team CRI is Fundraising for a World Immune to Cancer at the United Airlines NYC Half Marathon

    The Cancer Research Institute (CRI) is proud to be hosting 15 runners in the 2024 United Airlines…
    March 12, 2024| Max Mallet
Previous Page
1 … 5 6 7 8 9 … 20
Next Page

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute